These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17199862)

  • 21. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR
    J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Renal calcium excretion and urolithiasis].
    Aruga S; Honma Y
    Clin Calcium; 2011 Oct; 21(10):1465-72. PubMed ID: 21960231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of 1,25-dihydroxicolecalciferol and dietary calcium-phosphate on distribution of lead to tissues during growth.
    Cortina-Ramírez GE; Cerbón-Solorzano J; Calderón-Salinas JV
    Toxicol Appl Pharmacol; 2006 Jan; 210(1-2):123-7. PubMed ID: 16223518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic studies in kidney stone disease.
    Wong SY; Slater SR; Evans RA; Mason R; Lancaster EK; Acland SM; Eade Y; Hills E; Dunstan CR
    Q J Med; 1992 Mar; 82(299):247-58. PubMed ID: 1631259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of renal function on urinary mineral excretion and stone composition.
    Kadlec AO; Greco KA; Fridirici ZC; Gerber D; Turk TM
    Urology; 2011 Oct; 78(4):744-7. PubMed ID: 21664652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of Rongshi granule on renal stone formation and osteopontin expression in rat urolithiasis model].
    Huang P; Yang SW; Huang WH; Kong FZ; Lou YJ
    Zhongguo Zhong Yao Za Zhi; 2006 Jul; 31(14):1188-91. PubMed ID: 17048592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of high protein diet on stone-forming propensity and bone loss in rats.
    Amanzadeh J; Gitomer WL; Zerwekh JE; Preisig PA; Moe OW; Pak CY; Levi M
    Kidney Int; 2003 Dec; 64(6):2142-9. PubMed ID: 14633136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis.
    Baggio B; Budakovic A; Nassuato MA; Vezzoli G; Manzato E; Luisetto G; Zaninotto M
    Kidney Int; 2000 Sep; 58(3):1278-84. PubMed ID: 10972691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sodium excretion in children with lithogenic disorders].
    Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O
    Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary pH and stone formation.
    Wagner CA; Mohebbi N
    J Nephrol; 2010; 23 Suppl 16():S165-9. PubMed ID: 21170875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relative hypoparathyroidism and calcitriol up-regulation in hypercalciuric calcium renal stone formers--impact of nutrition.
    Hess B; Casez JP; Takkinen R; Ackermann D; Jaeger P
    Am J Nephrol; 1993; 13(1):18-26. PubMed ID: 8322837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethylene glycol induces hyperoxaluria without metabolic acidosis in rats.
    Green ML; Hatch M; Freel RW
    Am J Physiol Renal Physiol; 2005 Sep; 289(3):F536-43. PubMed ID: 15855660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated PTH levels in hypovitaminosis D are more rapidly suppressed by the administration of 1,25-dihydroxy-vitamin D3 than by vitamin D3.
    Theiler R; Bischoff H; Tyndall A; Stähelin HB
    Int J Vitam Nutr Res; 1998; 68(1):36-41. PubMed ID: 9503046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chlorthalidone Is Superior to Potassium Citrate in Reducing Calcium Phosphate Stones and Increasing Bone Quality in Hypercalciuric Stone-Forming Rats.
    Krieger NS; Asplin JR; Granja I; Ramos FM; Flotteron C; Chen L; Wu TT; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2019 Jul; 30(7):1163-1173. PubMed ID: 31101664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D, Hypercalciuria and Kidney Stones.
    Letavernier E; Daudon M
    Nutrients; 2018 Mar; 10(3):. PubMed ID: 29562593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Credentials of Spirulina diet on stability and flux related properties on the biomineralization process during oxalate mediated renal calcification in rats.
    Farooq SM; Ebrahim AS; Asokan D; Sakthivel R; Savitha S; Rajesh NG; Varalakshmi P
    Clin Nutr; 2005 Dec; 24(6):932-42. PubMed ID: 16084629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiotic treatment-induced tubular dysfunction as a risk factor for renal stone formation in cystic fibrosis.
    Böhles H; Gebhardt B; Beeg T; Sewell AC; Solem E; Posselt G
    J Pediatr; 2002 Jan; 140(1):103-9. PubMed ID: 11815772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The preventive effect of sodium pentosan polysulfate against renal stone formation in hyperoxaluric rats.
    Nakatani T; Ishii K; Yoneda Y; Kamikawa S; Kanazawa T; Sugimoto T; Osswald H
    Urol Res; 2002 Oct; 30(5):329-35. PubMed ID: 12389123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.